Anxiety
Updated: 07/31/2006

References

Allgulander C, Lavori PW. Excess mortality among 3302 patients with ‘pure’ anxiety neurosis. Arch Gen Psychiatry. 1991;48(7):599–602.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.

Andreatini R, Sartori VA et al. Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phytother Res. 2002 Nov;16(7):650–4.

Atmaca M, Tezcan E et al. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2005 Oct;59(5):616–20.

Barlow DH. Cognitive-behavioral therapy for panic disorder: Current status. J Clin Psychiatry. 1997;58(Suppl 2):32–6.

Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatric Services. 2000;51:1130–4.

Bell C, Abrams J et al. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry. 2001;178:399–405.

Bhattacharya SK, Bhattacharya A et al, Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study. Phytomedicine. 2000 Dec;7(6):463–9.

Birzniece V, Backstrom T et al. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Brain Res Rev. 2006 Aug;51(2):212–39.

Bourden KH, Rae DS et al. Estimating the prevalence of mental disorders in U.S. adults from the epidemiologic catchment area survey. Public Health Reports. 1992;107:663–8.

Bourdet C, Goldenberg F. Insomnia in anxiety: Sleep EEG changes. J Psychosom Res. 1994;38(Suppl 1):93–104.

Bourin M, Lambert O. Pharmacotherapy of anxious disorders. Hum Psychopharmacol Clin Exp. 2002;17:383–400.

Bruce M, Scott N et al. Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry. 1992;49(11):867–9.

Cagnacci A, Arangino S et al. Kava-kava administration reduces anxiety in perimenopausal women. Maturitas. 2003;44:103–9.

Carmack CL, Boudreaux E et al. Aerobic fitness and leisure physical activity as moderators of the stress-illness relation. Ann Behav Med. 1999;21(3):251–7.

Cohen H, Maayan R et al. Decreased circulatory levels of neuroactive steroids in behaviourally more extremely affected rats subsequent to exposure to a potentially traumatic experience. Int J Neuropsychopharmacol. Forthcoming.

Cook B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000;50(455):493–6.

Coryell W. Panic disorder and mortality. Psychiatric Clin North Am. 1988;11(2):433–40.

Coryell W, Noyes R Jr et al. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 1986;143(4):509–10.

Edzard E. The risk-benefit profile of commonly used herbal therapies: Gingko, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med. 2002;136:42–53.

Ernst E. Herbal remedies for anxiety: A systematic review of controlled clinical trials. Phytomedicine. 2006 Feb;13(3):205–8.

Fernstrom J. Can nutrient supplements modify brain function? J Clin Nutr 2000;71(S):1669S–73S.

Feurte S, Gerozissis K et al. Plasma Trp/LNAA ratio increases during chronic ingestion of an alpha-lactalbumin diet in rats. Nutr Neurosci. 2001;4(5):413–8.

Field T, Ironson G et al. Massage therapy reduces anxiety and enhances EEG pattern of alertness and math computations. Int J Neurosci. 1996;86(3-4):197–205.

Field T, Quintino O et al. Job stress reduction therapies. Altern Ther Health Med. 1997;3(4):54–6.

Friede M, Henneicke von Zepelin HH et al. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John’s wort. Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S38–41.

Frye CA, Sumida K et al. Progesterone’s effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology (Berl). 2006 Jun;186(3):312–22.

Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine. 1999;61:712–28.

Gaylord C, Orme-Johnson D et al. The effects of the transcendental mediation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults. Int J Neurosci. 1989;46(1-2):77–86.

Gelenberg AJ, Wojcik JD et al. Tyrosine for depression. J Psychiatr Res. 1982;17:175–80.

Goldberg C. Cognitive-behavioral therapy for panic: Effectiveness and limitations. Psychiatr Q. 1998;69(1):23–44.

Goodwin RD. The prevalence of panic attacks in the United States: 1980 to 1995. Journal of Clinical Epidemiology. 2003;(56):914–16.

Gupta YK, Gupta M et al. Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian J Physiol Pharmacol. 2003;47(4):373–86.

Hamazaki T, Sawazaki S et al. Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress. Lipids. 1999;34 Suppl:S33–7.

Harvey AG, Bryant RA et al. Cognitive behavior therapy for posttraumatic stress disorder. Clin Psychol Rev. 2003;23(3):501–22.

Heimberg RG. Cognitive-behavioral therapy for social anxiety disorder: Current status and future directions. Biol Psychiatry. 2002;51(1):101–8.

Hobbs C. Medicinal Mushrooms. Santa Cruz, CA: Botanica Press; 1995.

Jenike MA. Clinical practice: Obsessive-compulsive disorder. New Engl J Med. 2004;350:259–65.

Jin P. Efficacy of tai chi, brisk walking, meditation, and reading in reducing mental and emotional stress. J Psychosom Res. 1992;36(4):361–70.

Jorm AF, Christensen H et al. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust. 2004 Oct 4;181(7 Suppl):S29–46.

Kabat-Zinn J. Full Catastrophe Living. New York: Delacorte; 1990.

Kabat-Zinn J. Wherever You Go, There You Are. New York: Hyperion; 1994.

Kabat-Zinn J, Massion AO et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry. 1992;149(7):936–43.

Kakuda T. Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull. 2002 Dec;25(12):1513–8.

Kakuda T, Nozawa A et al. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem. 2000 Feb;64(2):287–93.

Katula JA, Blissmer BJ et al. Exercise intensity and self-efficacy effects on anxiety reduction in healthy, older adults. J Behav Med. 1999;22(3):233–47.

Kennedy DO, Little W et al. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006 Feb;20(2):96–102.

Kent JM, Mathew SJ et al. Molecular targets in the treatment of anxiety. Biol Psychiatry. 2002;52:1008–30.

Kuribara H, Weintraub ST et al. An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice. J Nat Prod. 2003 Oct;66(10):1333–7.

Leonard BE. The HPA and immune axes in stress: The involvement of the serotonergic system. Eur Psychiatry. 2005 Oct;20 Suppl 3:S302–6.

Leyton M, Pun VK et al. A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans. J Psychiatry Neurosci. 2003;28(6):464–7.

Lu K, Gray MA et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol. 2004 Oct;19(7):457–65.

Malathi A, Damodaran A. Stress due to exams in medical students: Role of yoga. Indian J Physiol Pharmacol. 1999;43(2):218–24.

March JS, Franklin M et al. Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol. 2001;30(1):8–18.

Margolin G, Gordis EB. The effects of family and community violence on children. Annu Rev Psychol. 2000;51:445–79.

Maron E, Toru I et al. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol. 2004 Jun;18(2):194–9.

McCraty R, Barrios-Choplin B et al. The impact of a new emotional self-management program on stress, emotions, heart rate variability, DHEA and cortisol. Integr Physiol Behav Sci. 1998;33(2):151–70.

Miller JJ, Fletcher K et al. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry. 1995;17(3):192–200.

Mishra LC, Singh BB et al. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review. Altern Med Rev. 2000 Aug;5(4):334–46.

Muller D, Pfeil T et al. Treating depression comorbid with anxiety: Results of an open, practice-oriented study with St John’s wort WS 5572 and valerian extract in high doses. Phytomedicine. 2003;10 Suppl 4:25–30.

Muller JE, Koen L et al. Anxiety and medical disorders. Curr Psychiatry Rep. 2005 Aug;7(4):245–51.

Narrow WE, Rae DS et al. Revised prevalence estimates of mental disorders in the United States. Arch Gen Psychiatry. 2002;59:115–23.

Nathan PJ, Burrows GD et al. Subsensitive melatonin suppression by dim white light: Possible biological marker of panic disorder. Int J Neuropsychopharmacol. 1998 Dec;1(2):115–120.

Nemeroff CB. Anxiolytics: Past, present and future agents. J Clin Psychiatry. 2003;64(Suppl 3):3–6.

Otto MW, Smits JA et al. Cognitive-behavior therapy for the treatment of anxiety disorders. J Clin Psychiatry. 2004;65(Suppl 5):34–41.

Rouillon F. Long term therapy of generalized anxiety disorder. Eur Psychiatry. 2004;19 (2):96–101.

Rush AJ Jr, Pincus HA et al. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000.

Saavedra M, Contreras CM et al. Differential progesterone effects on defensive burying and forced swimming tests depending upon a gradual decrease or an abrupt suppression schedules. Pharmacol Biochem Behav. 2006 Jan;83(1):130–5.

Sabelli HC, Fawcett J et al. Clinical studies on the phenylethylamine hypothesis of affective disorder: Urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry. 1986;47(2):66–70.

Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: A unifying theory. Clin Psychol Rev. 2001;21(1):33–61.

Schatzberg AF. Overview of anxiety disorders: Prevalence, biology, course, and treatment. J Clin Psychiatry. 1991;52(Suppl):5–9.

Shapiro SL, Schwartz GE et al. Effects of mindfulness-based stress reduction on medical and premedical students. J Behav Med. 1998;21(6):581–99.

Smriga M, Torii K. L-lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci U.S.A. 2003;100(26):15370–5.

Smriga M, Ghosh S et al. Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria. Proc Natl Acad Sci U.S.A. 2004;101(22):8285–8.

Smriga M, Kameishi M et al. Dietary L-lysine deficiency increases stress induced anxiety and fecal excretion in rats. J Nutr. 2002;132:3744–6.

Strous RD, Maayan R et al. The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside. Eur Neuropsychopharmacol. 2006 Apr;16(3):155–69.

Tonks A. Treating generalized anxiety disorder. Brit Med J. 2003;326:700–2.

Wakefield M, Pallister R. New hope for a disabling condition: Cognitive-behavioral approaches to panic disorder. J Psychosoc Nurs Ment Health Serv. 1997;35(3):12–20.

Wittchen HU. Generalized anxiety disorder: Prevalence, burden and cost to society. Depression and Anxiety. 2002;16:162–71.

Wittchen HU, Zhao S et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(5):355–64.

Witte S, Loew D et al. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders. Phytother Res. 2005 Mar;19(3):183–8.

Yehuda S, Rabinovitz S et al. Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci. 2005 Aug;8(4):265–7.

Yokogoshi H, Kobayashi M et al. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998;23(5):667–73.